You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Figure INF-3. HIV prevalence among injecting drug users: studies with national and sub-national coverage

Part (i) All injecting drug users, 2010–11

Country	year	National			Sub-national
Related links:
Hungary	2011	0			0	0	0
Malta	2011	0
Turkey	2011	0.3
Slovakia	2011	0.4			0
Czech Republic	2011	0.9	0.2	0.3
Cyprus	2011	0.1	1.4
United Kingdom	2011	1.2			1.3	0.3	0.6
Luxembourg	2011	1.8
Netherlands^^	2010/2011				3.7	0
Slovenia	2011	1.9			0.5
Austria	2011	0.4	3.9		2.3	0	0
Norway	2011	2.3			0.6
Bulgaria	2011				2.8
Poland	2011	2.9
Greece	2011	4.4	3.7		5.6	8.1	7.5	1	0	0	0	0	0	0	0	0	0	0
Belgium	2011				4.6	8.3	0
Sweden	2010				4.4
Germany	2011				3.9	5.6
France	2010	7.2
Lithuania	2010				5	6.7	21	18	7.1	0
Portugal	2010/2011	4.9	16.5
Latvia**	2011	11.2			32.1	2.9	6.1	20
Italy*	2010	11.5			5.1	5.0	4.0	3.3	2.7	5.3	20.9	38.1	4.4	2.2	6.3	29.4	4.0	10.7	9.9	7.7	6.9	10.0
Romania	2011	12
Spain	2010	34
Estonia	2010				53
Finland
Ireland
Denmark
Croatia
https://www.emcdda.europa.eu/stats13/inffig3a : Figure INF-3 parti
For primary sources, study details and data before 2010, see INF-8 and INF-0
See also 'General notes for interpreting data' on the Explanatory notes and help page

Notes:

Black squares indicate samples with national coverage; blue triangles indicate samples with sub-national (including local or regional) coverage.

Differences between countries have to be interpreted with caution owing to different types of settings and/or study methods; national sampling strategies vary.

Countries are presented by order of increasing prevalence, based on the average of national data or, if not available, of sub-national data.

Sources:

Reitox Network

Country	Hungary	Malta	Turkey	Slovakia	Czech Republic	Cyprus	United Kingdom	Luxembourg	Netherlands^^	Slovenia	Austria	Norway	Bulgaria	Poland	Greece	Belgium	Sweden	Germany	France	Lithuania	Portugal	Latvia**	Italy*	Romania	Spain	Estonia
National	0	0	0.3	0.4	0.9	0.1	1.2	1.8		1.9	0.4	2.32		2.9	4.4				7.2		4.9	11.2	11.5	11.6	33.6
National					0.2	1.4					3.9				3.7						16.5
National					0.3
Subnational	0			0			1.3		3.7	0.5	2.27	0.56	2.8		5.6	4.6	4.4	3.9		5		32.1	5.1			52.6
Subnational	0						0.3		0		0				8.1	8.3		5.6		6.7		2.9	5.0
Subnational	0						0.6				0				7.5	0				21.4		6.1	4.0
Subnational															1					18.4		19.8	3.3
Subnational															0					7.1			2.7
Subnational															0					0			5.3
Subnational															0								20.9
Subnational															0								38.1
Subnational															0								4.4
Subnational															0								2.2
Subnational															0								6.3
Subnational															0								29.4
Subnational															0								4.0
Subnational															0								10.7
Subnational																							9.9
Subnational																							7.7
Subnational																							6.9
Subnational																							10.0

inffig3a

Demonstration	Reference	Type	Y Axis	X axis	Label	Width (%)	Height (px)	Y plotline	Y min,max values	series Markers
	szrfig1	column,column,line	Quantity (kg)\|Number of seizures$3
	szrfig2	column,column,line	Quantity (kg)\|Number of seizures$3
	gpsfig4a	line	%				500		0,30
	gpsfig1	column	%				500		0,25
	gpsfig2	column,column,point	Contiuation rates %\|LTP all adults$3						0,
	gpsfig18a	distribution	Estimated prevalence (%)						0
	gpsfig18b	distribution	Estimated prevalence (%)						0
	gpsfig20	column	%				600		0,20
	dlofig2	stackedBar	%				600
	dlofig3	line	Index (2006 = 100)			68
	dlofig3$	pie			1 135 701 reports (2011)	30
	dlofig4	line	Index (2006 = 100)			68
	dlofig4$	pie			915 541 reports (2011)	30
	dlofig5	line	Index (2006 = 100)			68
	dlofig5$	pie			179 418 reports (2011)	30
	drdfig12a	scatter	Ratio between DRD in 2003 and 2000	Number of DRD in 2000				1
	drdfig12b	scatter	Ratio between DRD in 2010/11 and 2003	Number of DRD in 2003				1
	hsrfig2	stackedColumn	Clients in substitution treatment
	dlofig1	line	Index (2006 = 100)						60,180
	drdfig1	column	Country and total number of DRD				600
	drdfig2	column	Proportion of DRD under the age of 25 (%)				600
	drdfig3	line	Mean age in years
	drdfig4	line	Mean age in years
	drdfig5a	line	Index (1990 = 100)
	drdfig5b	line	Index (1996 = 100)
	drdfig6	line	Index (1990 = 100 %)						80,160
	drdfig7a	column	Mortality rate per million
	drdfig7b	column,point	Rate per million
	drdfig8	line	Index (1985 = 100 %)						50,650
	drdfig9a	line	%						0,70
	drdfig9b	line	%
	drdfig9c	line	%
	drdfig10	column	Mean age in years				500
	drdfig11a	line	Index						0,300
	drdfig11b	line	Index
	drdfig11c	line	Index
	drdfig13a	line	Number of cases
	drdfig13b	line	Number of cases
	eyefig1a	line
	eyefig1b	line
	eyefig1c	line							0,
	eyefig1d	line	%			45	800
	eyefig1d$	line	%			45	800
	gpsfig3	column	%				500
	gpsfig4b	line	%
	gpsfig5	column	%
	gpsfig6	column	%
	gpsfig7	column	%
	gpsfig8a	line	%						0,
	gpsfig8b	line	%						0,
	gpsfig9a	column	%
	gpsfig9b	column	%
	gpsfig10	line	%
	gpsfig11	column,column,point	Continuation rates (%)\| LTP All adults$3
	gpsfig12a	line	%						0,
	gpsfig12b	line	%						0,
	gpsfig13	column,column,point	%
	gpsfig14a	line	%						0,
	gpsfig14b	line	%						0,
	gpsfig15	column	%
	gpsfig16	column,column,point	Continuation rates (%)\|LTP All adults$3						0,
	gpsfig17	column	%
	gpsfig21a	line	%						0,
	gpsfig21b	line	%						0,
	gpsfig22	column,column,point	Continuation rates (%)\| LTP All adults$3
	gpsfig23a	line	%
	gpsfig23b	line	%
	gpsfig23c	line	%
	gpsfig23d	line	%						0,
	gpsfig23e	line	%						0,
	hsrfig4	pie			% of prison population in OST	30
	inffig1a	line	New AIDS cases per million population				700		0,
	inffig1b	line	New AIDS cases per million population				700		0,
	inffig2a	line	Cases per million population						0,
	inffig2b	line	Cases per million population						0,
	inffig2c	line	Cases per million population
	inffig2d	line	Cases per million population
	inffig3a	distribution	%						0,	National;Subnational\|square;rgba(0,0,0,0.8);triangle;rgba(0,0,255,0.8)
	inffig3b	distribution	%						0,	National;Subnational\|square;rgba(0,0,0,0.8);triangle;rgba(0,0,255,0.8)
	inffig3c	distribution	%						0,	National;Subnational\|square;rgba(0,0,0,0.8);triangle;rgba(0,0,255,0.8)
	inffig6a	distribution	%						0,	National;Subnational\|square;rgba(0,0,0,0.8);triangle;rgba(0,0,255,0.8)
	inffig6b	distribution	%						0,	National;Subnational\|square;rgba(0,0,0,0.8);triangle;rgba(0,0,255,0.8)
	inffig6c	distribution	%						0,	National;Subnational\|square;rgba(0,0,0,0.8);triangle;rgba(0,0,255,0.8)
	inffig9a	distribution	%						0,	National;Subnational\|square;rgba(0,0,0,0.8);triangle;rgba(0,0,255,0.8)
	inffig9b	distribution	%						0,	National;Subnational\|square;rgba(0,0,0,0.8);triangle;rgba(0,0,255,0.8)
	pppfig1	line	Index (2005 = 100)
	pppfig2	line	Index (2005 = 100)
	tdifig1a	line	%
	tdifig1b	line
	tdifig2a	pie				30
	tdifig2b	pie				50
	tdifig3a	line	%
	tdifig3b	line
	tdifig7	line	%			60			0,
	tdifig7$	stackedColumn	Numbers			38			0,50000
	hsrfig1b	stackedColumn	%































Distirbuted points with specific markers and colours	inffig6a	distribution	%							National;Subnational\|square;rgba(0,0,0,0.8);triangle;rgba(0,0,255,0.8)

Download spreadsheet version (.xls)